The stock has rallied nearly 40% from its 52-week low of Rs 922.45, the stock hit in May, this year. Its one-year returns stand at 27% which is higher than 16% returns given by broader Nifty during this period while lower than the Nifty Pharma index which has given over 29% returns.
| Subscribe To Our Free Newsletter |
